1. Daftari BesheliL, AranS, ShaqdanK, et al.Current status of nephrogenic systemic fibrosis. Clin Radiol2014;69:661. CrossRef

2. ThomsenHS, MorcosSK, AlmenT, et al.Nephrogenic systemic fibrosis and gadolinium‐based contrast media: updated ESUR Contrast Medium Safety Committee guidelines. Eur Radiol2013;23:307. CrossRef

3. ManikkavasakarS, AlObaidyM, BusireddyKK, et al.Magnetic resonance imaging of pancreatitis: an update. World J Gastroenterol2014;20:14760. CrossRef

4. DiMagnoMJ, DimagnoEP. Chronic pancreatitis. Curr Opin Gastroenterol2006;22:487.

5. O'NeillEK, CogleyJR, MillerFH. The ins and outs of liver imaging. Clin Liver Dis2015;19:99. CrossRef

6. SiegelmanES, ChauhanA. MR characterization of focal liver lesions: pearls and pitfalls. Magn Reson Imaging Clin N Am2014;22:295. CrossRef

7. CogleyJR, MillerFH. MR imaging of benign focal liver lesions. Radiol Clin North Am2014;52:657. CrossRef

8. NaganoY, MatsuoK, GoraiK, et al.Bile duct hamartomas (von Mayenburg complexes) mimicking liver metastases from bile duct cancer: MRC findings. World J Gastroenterol2006;12:1321.

9. Garcia‐EulateR, HussainN, HellerT, et al.CT and MRI of hepatic abscess in patients with chronic granulomatous disease. AJR Am J Roentgenol2006;187:482. CrossRef

10. NakagawaraM, HanaiH, KajimuraM. Images in clinical medicine. Detection of liver abscesses by T1‐weighted magnetic resonance imaging. N Engl J Med2004;351:1013. CrossRef

11. KimYK, KimCS, LeeJM, et al.Solid organizing hepatic abscesses mimic hepatic tumor: multiphasic computed tomography and magnetic resonance imaging findings with histopathologic correlation. J Comput Assist Tomogr2006;30:189. CrossRef

12. ChoiBY, NguyenMH. The diagnosis and management of benign hepatic tumors. J Clin Gastroenterol2005;39:401. CrossRef

13. KimYH, SainiS, BlakeMA, et al.Distinguishing hepatic metastases from hemangiomas: qualitative and quantitative diagnostic performance through dual echo respiratory‐triggered fast spin echo magnetic resonance imaging. J Comput Assist Tomogr2005;29:571. CrossRef

14. MathieuD, Caseiro‐AlvesF. Imaging of benign liver lesions. JBR‐BTR2004;87:76.

15. MotoharaT, SemelkaRC, NagaseL. MR imaging of benign hepatic tumors. Magn Reson Imaging Clin North Am2002;10:1. CrossRef

16. YuJS, RofskyNM. Hepatic metastases: perilesional enhancement on dynamic MRI. AJR Am J Roentgenol2006;186:1051. CrossRef

17. FinleyAC, HoseyJR, NooneTC, et al.Multiple focal nodular hyperplasia syndrome: diagnosis with dynamic, gadolinium‐enhanced MRI. Magn Reson Imaging2005;23:511. CrossRef

18. SabaL, di MartinoM, de CeccoCN, et al.Diagnostic confidence of computed tomography and magnetic resonance in focal liver pathology. Eur J Gastroenterol Hepatol2015;27:97. CrossRef

19. GrazioliL, MoranaG, KirchinMA, et al.Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine‐enhanced MR imaging: prospective study. Radiology2005;236:166. CrossRef

20. DonatiF, BoraschiP, GigoniR, et al.Focal nodular hyperplasia of the liver: diffusion and perfusion MRI characteristics. Magn Reson Imaging2013;31:10. CrossRef

21. PrasadSR, WangH, RosasH, et al.Fat‐containing lesions of the liver: radiologic–pathologic correlation. Radiographics2005;25:321. CrossRef

22. KebapciM, KayaT, AslanO, et al.Hepatic adenomatosis: gadolinium‐enhanced dynamic MR findings. Abdom Imaging2001;26:264. CrossRef

23. LeeYJ, LeeJM, LeeJS, et al.Hepatocellular carcinoma: diagnostic performance of multidetector CT and MR imaging‐A systematic review and meta‐analysis. Radiology2015;275:97. CrossRef

24. DigumarthySR, SahaniDV, SainiS. MRI in detection of hepatocellular carcinoma (HCC). Cancer Imaging2005;5:20. CrossRef

25. KimYK, KwakHS, KimCS, et al.Hepatocellular carcinoma in patients with chronic liver disease: comparison of SPIO‐enhanced MR imaging and 16‐detector row CT. Radiology2006;238:531. CrossRef

26. DietrichCF, KratzerW, StrobeD, et al.Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast‐enhanced sonography versus CT and MRI. World J Gastroenterol2006;12:1699.

27. PetraliaG, PadhaniA, SummersP, et al.Whole‐body diffusion‐weighted imaging: is it all we need for detecting metastases in melanoma patients?Eur Radiol2013;23:3466. CrossRef

28. KanematsuM, GoshimaS, KondoH, et al.Reply: How far do we need to elaborate the quality of diffusion‐weighted MR images of the liver?Abdom Imaging2013;38:1183. CrossRef

29. AkayS, KocaogluM, EmerO, et al.Diagnostic accuracy of whole‐body diffusion‐weighted magnetic resonance imaging with 3.0 T in detection of primary and metastatic neoplasms. J Med Imaging Radiat Oncol2013;57:274. CrossRef

30. DajbogE, LefterLP, ScripcariuV, et al.Diagnostic features of benign pancreatic insulinomas. An analysis of three cases. J Gastrointest Liver Dis2006;15:61.

31. HanninenEL, PechM, JonasS, et al.Magnetic resonance imaging including magnetic resonance cholangiopancreatography for tumor localization and therapy planning in malignant hilar obstructions. Acta Radiol2005;46:462. CrossRef

32. BragaL, SemelkaRC. Magnetic resonance imaging features of focal liver lesions after intervention. Top Magn Reson Imaging2005;16:99. CrossRef

33. BragaL, SemelkaRC, PietrobonR, et al.Does hypervascularity of liver metastases as detected on MRI predict disease progression in breast cancer patients?AJR Am J Roentgenol2004;182:1207. CrossRef

34. KimSK, LimHK, KimYH, et al.Hepatocellular carcinoma treated with radio‐frequency ablation: spectrum of imaging findings 1. Radiographics2003;23:107. CrossRef

35. KieransAS, ElazzaziM, BragaL, et al.Thermoablative treatments for malignant liver lesions: 10‐year experience of MRI appearances of treatment response. AJR Am J Roentgenol2010;194:523. CrossRef

36. DanradR, MartinDR. MR imaging of diffuse liver diseases. Magn Reson Imaging Clin North Am2005;13:277, vi. CrossRef

37. HussainHK, ChenevertTL, LondyFJ, et al.Hepatic fat fraction: MR imaging for quantitative measurement and display. Early experience. Radiology2005;237:1048. CrossRef

38. PilleulF, ChaveG, DumortierJ, et al.Fatty infiltration of the liver. Detection and grading using dual T1 gradient echo sequences on clinical MR system. Gastroenterol Clin Biol2005;29:1143. CrossRef

39. ChiangHJ, LinLH, LiCW, et al.Magnetic resonance fat quantification in living donor liver transplantation. Transplant Proc2014;46:666. CrossRef

40. QayyumA, GohJS, KakarS, et al.Accuracy of liver fat quantification at MR imaging: comparison of out‐of‐phase gradient‐echo and fat‐saturated fast spin‐echo techniques. Initial experience. Radiology2005;237:507. CrossRef

41. BalassyC, FeierD, Peck‐RadosavljevicM, et al.Susceptibility‐weighted MR imaging in the grading of liver fibrosis: a feasibility study. Radiology2014;270:149. CrossRef

42. VirtanenJM, PudasTK, RatilainenJA, et al.Iron overload: accuracy of in‐phase and out‐of‐phase MRI as a quick method to evaluate liver iron load in haematological malignancies and chronic liver disease. Br J Radiol2012;85:e162. CrossRef

43. AlustizaJM, ArtetxeJ, CastiellaA, et al.MR quantification of hepatic iron concentration. Radiology2004;230:479. CrossRef

44. WoodJC, EnriquezC, GhugreN, et al.MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion‐dependent thalassemia and sickle cell disease patients. Blood2005;106:1460. CrossRef

45. GandonY, OlivieD, GuyaderD, et al.Non‐invasive assessment of hepatic iron stores by MRI. Lancet2004;363:357. CrossRef

46. BilajF, HyslopWB, RiveroH, et al.MR imaging findings in autoimmune hepatitis: correlation with clinical staging. Radiology2005;236:896. CrossRef

47. MartinDR, SeibertD, YangM, et al.Reversible heterogeneous arterial phase liver perfusion associated with transient acute hepatitis: findings on gadolinium‐enhanced MRI. J Magn Reson Imaging2004;20:838. CrossRef

48. MartinDR, SemelkaRC. Magnetic resonance imaging of the liver: review of techniques and approach to common diseases. Semin Ultrasound CT MR2005;26:116. CrossRef

49. KoinumaM, OhashiI, HanafusaK, et al.Apparent diffusion coefficient measurements with diffusion‐weighted magnetic resonance imaging for evaluation of hepatic fibrosis. J Magn Reson Imaging2005;22:80. CrossRef

50. InoueT, KudoM, WataiR, et al.Differential diagnosis of nodular lesions in cirrhotic liver by post‐vascular phase contrast‐enhanced US with Levovist: comparison with superparamagnetic iron oxide magnetic resonance images. J Gastroenterol2005;40:1139. CrossRef

51. HennedigeTP, NeoWT, VenkateshSK. Imaging of malignancies of the biliary tract‐an update. Cancer Imaging2014;14:14.

52. PatelT. Cholangiocarcinoma. Nat Clin Pract Gastroenterol Hepatol2006;3:33. CrossRef

53. SinghP, PatelT. Advances in the diagnosis, evaluation and management of cholangiocarcinoma. Curr Opin Gastroenterol2006;22:294. CrossRef

54. O'ReganDP, FitzgeraldJ, AllsopJ, et al.A comparison of MR cholangiopancreatography at 1.5 and 3.0 Tesla. Br J Radiol2005;78:894. CrossRef

55. KamisawaT, TuY, EgawaN, et al.MRCP of congenital pancreaticobiliary malformation. Abdom Imaging2007;32:129. CrossRef

56. ŞurlinV, SăftoiuA, DumitrescuD. Imaging tests for accurate diagnosis of acute biliary pancreatitis. World J Gastroenterol2014;20:16544. CrossRef

57. TamuraR, IshibashiT, TakahashiS. Chronic pancreatitis: MRCP versus ERCP for quantitative caliber measurement and qualitative evaluation. Radiology2006;238:920. CrossRef

58. MoreraFJ. Magnetic resonance cholangiography in gallstone pancreatitis. Ann Surg2006;244:159. CrossRef

59. LeeNJ, KimKW, KimTK, et al.Secretin‐stimulated MRCP. Abdom Imaging2006;31:575. CrossRef

60. IchikawaT, SouH, ArakiT, et al.Duct Penetrating Sign at MRCP: usefulness of differentiating inflammatory pancreatic mass from pancreatic carcinoma. Radiology2001;221:107. CrossRef

61. GillamsAR, KurzawinskiT, LeesWR. Diagnosis of duct disruption and assessment of pancreatic leak with dynamic secretin‐stimulated MR cholangiopancreatography. AJR Am J Roentgenol2006;186:499. CrossRef

62. SandrasegaranK, NutakkiK, TahirB, et al.Use of diffusion‐weighted MRI to differentiate chronic pancreatitis from pancreatic cancer. AJR Am J Roentgenol2013;201:1002. CrossRef

63. ParkHS, LeeJM, ChoiHK, et al.Preoperative evaluation of pancreatic cancer: comparison of gadolinium‐enhanced dynamic MRI with MR cholangiopancreatography versus MDCT. J Magn Reson Imaging2009;30:586. CrossRef

64. O'NeillE, HammondN, MillerFH. MR imaging of the pancreas. Radiol Clin North Am2014;52:757. CrossRef

65. RomijnMG, StokerJ, van EijckCH, et al.MRI with mangafodipir trisodium in the detection and staging of pancreatic cancer. J Magn Reson Imaging2000;12:261. CrossRef

66. SchimaW, FuggerR, SchoberE, et al.Diagnosis and staging of pancreatic cancer: comparison of mangafodipir trisodium‐enhanced MR imaging and contrast‐enhanced helical hydro‐CT. AJR Am J Roentgenol2002;179:717. CrossRef

67. McAuleyG, DelaneyH, ColvilleJ, et al.Multimodality preoperative imaging of pancreatic insulinomas. Clin Radiol2005;60:1039. CrossRef

68. SpinelliKS, FromwillerTE, DanielRA, et al.Cystic pancreatic neoplasms: observe or operate. Ann Surg2004;239:651. CrossRef

69. LopezHE, PechM, RickeJ, et al.Magnetic resonance imaging in the assessment of cystic pancreatic lesions: differentiation of benign and malignant lesion status. Acta Radiol2006;47:121. CrossRef

70. SandJ, NordbackI. The differentiation between pancreatic neoplastic cysts and pancreatic pseudocyst. Scand J Surg2005;94:161.

71. PamuklarE, SemelkaRC. MR imaging of the pancreas. Magn Reson Imaging Clin North Am2005;13:313. CrossRef

72. KimYH, SainiS, SahaniD, et al.Imaging diagnosis of cystic pancreatic lesions: pseudocyst versus nonpseudocyst. Radiographics2005;25:671. CrossRef

73. SahaniDV, KadavigereR, BlakeM, et al.Intraductal papillary mucinous neoplasm of pancreas: multi‐detector row CT with 2D curved reformations. Correlation with MRCP. Radiology2006;238:560. CrossRef

74. TakahashiY, SakamotoY, ShimadaK, et al.Imaging features of large intraductal papillary mucinous carcinoma of the pancreatic tail. Pancreas2006;32:334. CrossRef

75. PeetersE, Op de BeeckB, OsteauxM. Primary pancreatic and renal non‐Hodgkin's lymphoma: CT and MR findings. JBR‐BTR2001;84:108.

76. KiresiDA, KivrakAS, EcirliS, et al.Secondary breast, pancreatic, and renal involvement with non‐Hodgkin's lymphoma: Imaging findings. Breast2006;15:106. CrossRef

77. ElsayesKM, NarraVR, Abou El AbbassHA, et al.Pancreatic tumors: diagnostic patterns by 3D gradient‐echo post contrast magnetic resonance imaging with pathologic correlation. Curr Probl Diagn Radiol2006;35:125. CrossRef

78. OikarinenH. Diagnostic imaging of carcinomas of the gallbladder and the bile ducts. Acta Radiol2006;47:345. CrossRef

79. JungSE, LeeJM, LeeK, et al.Gallbladder wall thickening: MR imaging and pathologic correlation with emphasis on layered pattern. Eur Radiol2005;15:694. CrossRef

80. PedrosaI, GuariseA, GoldsmithJ, et al.The interrupted rim sign in acute cholecystitis: a method to identify the gangrenous form with MRI. J Magn Reson Imaging2003;18:360. CrossRef

81. OhKY, GilfeatherM, KennedyA, et al.Limited abdominal MRI in the evaluation of acute right upper quadrant pain. Abdom Imaging2003;28:643. CrossRef

82. KazaRK, GulatiM, WigJD, et al.Evaluation of gallbladder carcinoma with dynamic magnetic resonance imaging and magnetic resonance cholangiopancreatography. Australas Radiol2006;50:212. CrossRef

83. AscentiG, VisalliC, GenitoriA, et al.Multiple hypervascular pancreatic metastases from renal cell carcinoma: dynamic MR and spiral CT in three cases. Clin Imaging2004;28:349. CrossRef

84. AsbachP, DeweyM, KlessenC, et al.Respiratory‐triggered MRCP applying parallel acquisition techniques. J Magn Reson Imaging2006;24:1095. CrossRef

85. KondoS, IsayamaH, AkahaneM, et al.Detection of common bile duct stones: comparison between endoscopic ultrasonography, magnetic resonance cholangiography, and helical‐computed‐tomographic cholangiography. Eur J Radiol2005;54:271. CrossRef

86. SchmidtS, ChevallierP, NovellasS, et al.Choledocholithiasis: repetitive thick‐slab single‐shot projection magnetic resonance cholangiopancreaticography versus endoscopic ultrasonography. Eur Radiol2007;17:241. CrossRef

87. GriffinN, WastleML, DunnWK, et al.Magnetic resonance cholangiopancreatography versus endoscopic retrograde cholangiopancreatography in the diagnosis of choledocholithiasis. Eur J Gastroenterol Hepatol2003;15:809. CrossRef

88. KatabathinaVS, DasyamAK, DasyamN, et al.Adult bile duct strictures: role of MR imaging and MR cholangiopancreatography in characterization. Radiographics2014;34:565. CrossRef

89. WeberC, KuhlencordtR, GrotelueschenR, et al.Magnetic resonance cholangiopancreatography in the diagnosis of primary sclerosing cholangitis. Endoscopy2008;40:739. CrossRef

90. VitellasKM, KeoganMT, FreedKS, et al.Radiologic manifestations of sclerosing cholangitis with emphasis on MR cholangiopancreatography. Radiographics2000;20:959. CrossRef

91. LeeJH, JangHS, KimJG, et al.Prediction of pathologic staging with magnetic resonance imaging after preoperative chemoradiotherapy in rectal cancer: pooled analysis of KROG 10‐01 and 11‐02. Radiother Oncol2014;113:18. CrossRef

92. ArrivéL, El MouhadiS. MR enterography versus MR enteroclysis. Radiology2013;266:688. CrossRef

93. SinhaR, RajeshA. MR imaging of the small bowel: is MR enteroclysis the only valid first‐line investigation?Radiology2013;266:689. CrossRef

94. KeelingAN, MorrinMM, McKenzieC, et al.Intravenous, contrast‐enhanced MR colonography using air as endoluminal contrast agent: impact on colorectal polyp detection. Eur J Radiol2012;81:31. CrossRef

95. RimolaJ, OrdásI. MR colonography in inflammatory bowel disease. Magn Reson Imaging Clin N Am2014;22:23. CrossRef

96. ThorntonE, MorrinMM, YeeJ. Current status of MR colonography. Radiographics2010;30:201. CrossRef

97. SinghK, SinghN, ThukralC, et al.Magnetic resonance imaging (MRI) evaluation of perianal fistulae with surgical correlation. J Clin Diagn Res2014;8:RC1. CrossRef